The usage of Raman spectroscopy for analytical high quality management of anticancer drug preparations in scientific pharmaceutical allotting models is growing in reputation, notably supported by commercially obtainable, objective designed devices. Though not legislatively obligatory, analytical strategies are incessantly used post-preparation to confirm the accuracy of a preparation when it comes to id and amount of the drug in answer. Nonetheless, whereas the fast, price efficient and label free evaluation achieved with Raman spectroscopy is interesting, it is very important perceive the molecular origin of the spectral contributions collected from the answer of actives and excipients, to guage the energy and limitation for the method, which can be utilized to establish and quantify both the prescribed business formulation, and/or the energetic drug itself, in personalised options.
Within the present research, 4 business formulations, Erbitux®, Truxima®, Ontruzant® and Avastin® of monoclonal antibodies (mAbs), corresponding respectively to cetuximab, rituximab, trastuzumab and bevacizumab have been used to focus on the important thing function of excipients in discrimination and quantification of the formulations. It’s demonstrated that protein based mostly anticancer medicine akin to mAbs have a comparatively weak Raman response, whereas excipients akin to glycine, trehalose or histidine contribute considerably to the spectra. Multivariate evaluation (partial least sq. regression and partial least sq. discriminant evaluation) additional demonstrates that the signatures of the mAbs themselves usually are not outstanding in mathematical fashions and that these of the excipients are solely liable for the differentiation of formulation and correct willpower of concentrations.
Whereas Raman spectroscopy can efficiently validate the conformity of mAbs intravenous infusion options, the idea for the evaluation ought to be thought of, and particular warning ought to be given to excipient compositions in business formulations to make sure reliability and reproducibility of the evaluation.
Preclinical and Scientific Improvement of Therapeutic Antibodies Concentrating on Features of CD47 within the Tumor Microenvironment
CD47 is a ubiquitously expressed cell floor glycoprotein that capabilities as a signaling receptor for thrombospondin-1 and because the counter-receptor for sign regulatory protein-α (SIRPα). Participating SIRPα on macrophages inhibits phagocytosis, and CD47 thereby serves as a physiological marker of self. Nonetheless, elevated CD47 expression on some most cancers cells additionally protects tumors from innate immune surveillance and limits adaptive antitumor immunity by way of inhibitory SIRPα signaling in antigen presenting cells. CD47 additionally mediates inhibitory thrombospondin-1 signaling in vascular cells, T cells, and NK cells, and blocking inhibitory CD47 signaling on cytotoxic T cells instantly will increase tumor cell killing.
Due to this fact, CD47 capabilities as an innate and adaptive immune checkpoint. These findings have led to the event of antibodies and different therapeutic approaches to dam CD47 capabilities within the tumor microenvironment. Preclinical research in mice demonstrated that blocking CD47 can restrict the expansion of hematologic malignancies and strong tumors and improve the efficacy of standard chemotherapy, radiation remedy, and a few focused most cancers therapies. Humanized CD47 antibodies are displaying promise in early scientific trials, however unwanted effects associated to enhanced phagocytic clearance of circulating blood cells stay a priority. Approaches to bypass these embody antibody preloading methods, growth of antibodies that acknowledge tumor-specific epitopes of CD47, SIRPα antibodies, and bivalent antibodies that limit CD47 blockade to particular tumor cells.
Preclinical and scientific growth of antibodies and associated biologics that inhibit CD47/SIRPα signaling are reviewed, together with methods to mix these brokers with numerous standard and focused therapeutics to enhance affected person end result for numerous cancers.
Most cancers in Systemic Sclerosis: Evaluation of antibodies in opposition to elements of the Th/To Complicated
Goal: The intention of this research is to explain 4 of the commonest autoantibodies in opposition to elements of the Th/To advanced: hPOP1, RPP25, RPP30, and RPP40. We report their prevalence and scientific traits in a systemic sclerosis (SSc) inhabitants, and decide whether or not these specificities affiliate with most cancers.
Strategies: A case management research was carried out using knowledge from the Johns Hopkins Scleroderma Heart Cohort. A complete of 804 grownup sufferers with SSc had been included; 401 SSc sufferers with no historical past of most cancers after a minimum of 5 years of illness had been in comparison with 403 SSc sufferers who ever had a historical past of most cancers. Antibodies in opposition to hPOP1, RPP25, RPP30, and RPP40 had been assayed by immunoprecipitation of 35 S-methionine-labeled proteins generated by in vitro transcription/translation. Demographic and scientific traits had been in contrast between teams.
Outcomes: 67/804 (8.3%) of sufferers had antibodies in opposition to any element of the Th/To advanced. Sufferers with antibodies to any element had been considerably extra more likely to have restricted cutaneous illness, much less more likely to have tendon friction rubs, and extra more likely to have findings in line with interstitial lung illness or pulmonary hypertension. Sufferers with antibodies in opposition to hPOP1, RPP25, RPP30, and/or RPP40 had been considerably much less more likely to develop most cancers inside 2 years of SSc-onset (0% vs 11%, p=0.016).
Mouse MDC (CCL22) |
MBS692094-5x002mg |
MyBiosource |
5x0.02mg |
EUR 1725 |
Mouse Monoclonal anti-human CCL-22 (MDC) |
hAP-0147 |
Angio Proteomie |
100ug |
EUR 250 |
MDC protein (Mouse) |
30R-AM058 |
Fitzgerald |
20 ug |
EUR 312 |
|
Description: Purified recombinant Mouse MDC protein |
MDC protein (Mouse) |
MBS539496-002mg |
MyBiosource |
0.02mg |
EUR 465 |
MDC protein (Mouse) |
MBS539496-5x002mg |
MyBiosource |
5x0.02mg |
EUR 1945 |
Anti-Mouse MDC Antibody |
103-P66 |
ReliaTech |
100 µg |
EUR 245.7 |
Description: Mouse MCD, the mouse orthologue of the human macrophagederived chemokine (MDC)/stimulated T cell chemotactic protein (STCP-1), is a CC chemokine cloned from activated mouse B cells. Mouse MDC cDNA encodes a precursor protein of 92 amino acid (aa) residues with a 24 aa residue predicted signal peptide that is cleaved to yield a 68 aa residue mature 7.8 kDa protein. At the amino acid sequence level, mouse and human MDC share 64% identity and 83% similarity. The genomic organization of the mouse and human MDC genes are very similar, exhibiting sequence identity at the intron-exon boundaries. Mouse MDC is expressed at high levels in dendritic cells and activated B lymphocytes. Low levels of mouse MDC mRNA are also detectable in lung, unstimulated spleen cells, lymph node cells and in thymocytes. MDC is a functional ligand for the CC chemokine receptor 4. Recombinant or chemically synthesized mature mouse MDC has been shown to induce chemotaxis or Ca2+ mobilization in activated mouse and human T cells. |
Mouse MDC ELISA Kit |
55R-1643 |
Fitzgerald |
1 kit |
EUR 633 |
|
Description: ELISA kit for detection of MDC in the research laboratory |
Mouse MDC ELISA Kit |
EMM0016 |
Abclonal |
96Tests |
EUR 625.2 |
Mouse MDC ELISA Kit |
EMM0217 |
Abclonal |
96Tests |
EUR 625.2 |
Mouse MDC ELISA kit |
E22-MC105.48 |
EnoGene |
48T |
EUR 295 |
|
Description: 4pg/ml |
Mouse MDC ELISA kit |
E22-MC105.96 |
EnoGene |
96T |
EUR 395 |
|
Description: 4pg/ml |
Mouse MDC ELISA Kit |
GWB-ZZD104 |
GenWay Biotech |
1x96 well plate |
Ask for price |
Mouse MDC ELISA kit |
LF-EK50241 |
Abfrontier |
1×96T |
EUR 777.6 |
Mouse MDC ELISA Kit |
MBS8579383-48Tests |
MyBiosource |
48Tests |
EUR 390 |
Mouse MDC ELISA Kit |
MBS8579383-5x96Tests |
MyBiosource |
5x96Tests |
EUR 2275 |
Mouse MDC ELISA Kit |
MBS8579383-96Tests |
MyBiosource |
96Tests |
EUR 495 |
Mouse MDC ELISA Kit |
MBS9135884-5x96Tests |
MyBiosource |
5x96Tests |
EUR 2615 |
Mouse MDC ELISA Kit |
MBS9135884-96Tests |
MyBiosource |
96Tests |
EUR 570 |
Mouse MDC (CCL22) Recombinant |
MBS553251-0005mg |
MyBiosource |
0.005mg |
EUR 165 |
Mouse MDC (CCL22) Recombinant |
MBS553251-002mg |
MyBiosource |
0.02mg |
EUR 245 |
MDC, CCL22, murine (mouse) |
RC335-33 |
Bio Basic |
5ug |
EUR 125.26 |
|
Mouse MDC ELISA kit (4X96T) |
LF-EK50242 |
Abfrontier |
4×96T |
EUR 2641.2 |
Mouse MDC PicoKine ELISA Kit |
MBS175846-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 2755 |
Mouse MDC PicoKine ELISA Kit |
MBS175846-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 600 |
Mouse CCL22/MDC ELISA Kit |
E28L0315 |
EnoGene |
96T |
EUR 666.67 |
MDC / CCL22 (Mouse) ELISA Kit |
MBS495367-5x96Tests |
MyBiosource |
5x96Tests |
EUR 3050 |
MDC / CCL22 (Mouse) ELISA Kit |
MBS495367-96Tests |
MyBiosource |
96Tests |
EUR 665 |
MDC / CCL22 Mouse ELISA Kit |
MBS355437-5x96Tests |
MyBiosource |
5x96Tests |
EUR 2190 |
MDC / CCL22 Mouse ELISA Kit |
MBS355437-96Tests |
MyBiosource |
96Tests |
EUR 485 |
Recombinant Mouse MDC/CCL22 protein |
CD00304-5ug |
Jiaxing Korain Biotech Ltd (BT Labs) |
5ug |
EUR 176 |
|
Description: CCL22 is a protein that in mouse is encoded by the CCL22 gene, which locates on the Chr. 8. It is highly expressed in macrophage, monocyte-derived dendritic cell and thymus, additionally, also detected in the tissues of thymus, lymph node and appendix. CCL22 can bind to CCR4, and is a chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells, but not for neutrophils, eosinophils, and resting T-lymphocytes. After secreted from monocyte-derived dendritic cells, the protein can be proteolytic cleaved into three forms: MDC (3-69), MDC (5-69), MDC (7-69). |
Mouse MDC (CCL22) Recombinant Protein |
M10-033 |
ReliaTech |
20 µg |
EUR 196.35 |
Description: MDC is a CC chemokine that is produced in B cells, macrophages, monocyte-derived dendritic cells, activated NK cells and CD4 T cells. It signals through the CCR4 receptor. MDC chemoattracts monocytes, dendritic cells and NK cells and exerts HIV suppressive activity. The 67 amino acid form of MDC displays reduced chemoattractant activity but retains HIV suppressive activity. Recombinant murine MDC is a 7.8 kDa protein containing 68 amino acid residues including the four highly conserved cysteine residues present in the CC chemokines. |
Mouse MDC (CCL22) Recombinant Protein |
M10-033S |
ReliaTech |
5 µg |
EUR 92.4 |
Description: MDC is a CC chemokine that is produced in B cells, macrophages, monocyte-derived dendritic cells, activated NK cells and CD4 T cells. It signals through the CCR4 receptor. MDC chemoattracts monocytes, dendritic cells and NK cells and exerts HIV suppressive activity. The 67 amino acid form of MDC displays reduced chemoattractant activity but retains HIV suppressive activity. Recombinant murine MDC is a 7.8 kDa protein containing 68 amino acid residues including the four highly conserved cysteine residues present in the CC chemokines. |
MDC ELISA Kit (Mouse) (OKBB00214) |
OKBB00214 |
Aviva Systems Biology |
96 Tests |
EUR 621.6 |
Description: Description of target: Macrophage-derived chemokine (MDC), also called Chemokine, cc motif, ligand 22 (CCL22) or Small inducible cytokine subfamily A, member 22 (SCY22). MDC is a recently identified member of the CC chemokine family. It is not closely related to other chemokines, sharing most similarity with thymus- and activation-regulated chemokine (TARC), which contains 37% identical amino acids. In addition, MDC gene is mapped to chromosome 16q13, the same position reported for the TARC gene. MDC has the four-cysteine motif and other highly conserved residues characteristic of CC chemokines, but it shares <35% identity with any of the known chemokines. Recombinant MDC was expressed in Chinese hamster ovary cells and purified by heparin-Sepharose chromatography. MDC is highly expressed in macrophages and in monocyte-derived dendritic cells, but not in monocytes, natural killer cells, or several cell lines of epithelial, endothelial, or fibroblast origin. High expression was also detected in normal thymus and less expression in lung and spleen. MDC is thus a unique member of the CC chemokine family that may play a fundamental role in the function of dendritic cells, natural killer cells, and monocytes.;Species reactivity: Mouse;Application: ELISA;Assay info: ;Sensitivity: < 1 pg/mL |
Mouse MDC Recombinant Protein Lyophilized |
IMSMDCRLY5UG |
Innovative research |
each |
EUR 341 |
|
Description: Mouse MDC Recombinant Protein Lyophilized |
Mouse MDC Recombinant Protein Lyophilized |
MBS8434270-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Anti-Human MDC Antibody |
102-P61 |
ReliaTech |
100 µg |
EUR 245.7 |
Description: MDC or CCL22, also named stimulated T cell chemotactic protein (STCP-1), is a CC chemokine initially isolated from clones of monocyte-derived macrophages. Human MDC cDNA encodes a precursor protein of 93 amino acid residues with a 24 amino acid residue predicted signal peptide that is cleaved to yield a 69 amino acid residue mature 8 kDa protein. At the amino acid sequence level, MDC shows less than 35% identity to other CC chemokine family members. Human MDC is expressed in dendritic cells, macrophages and activated monocytes. In addition, MDC expression is also detected in the tissues of thymus, lymph node and appendix. The gene for human MDC has been mapped to chromosome 16 rather than chromosome 17 where the genes for many human CC chemokines are clustered. Recombinant or chemically synthesized mature MDC has been shown to induce chemotaxis or Ca2+ mobilization in dendritic cells, IL2 activated NK cells, and activated T lymphocytes. A CD8+ T lymphocyte-derived secreted soluble activity that suppresses infection by primary non-syncytium-inducing and syncytium-inducing HIV1 isolates and the T cell line-adapted isolate HIV1 IIIB, has been identified as MDC. Based on aminoterminal sequence analysis, the major CD8 + T lymphocyte-derived MDC protein yielded an aminoterminal sequence of YGANM, which is two amino acid residues shorter than the predicted mature MDC. The difference in potency between the two mature MDC isoforms has not been determined. |
Anti-Human MDC Antibody |
101-M77 |
ReliaTech |
500 µg |
EUR 246.75 |
Description: MDC or CCL22, also named stimulated T cell chemotactic protein (STCP-1), is a CC chemokine initially isolated from clones of monocyte-derived macrophages. Human MDC cDNA encodes a precursor protein of 93 amino acid residues with a 24 amino acid residue predicted signal peptide that is cleaved to yield a 69 amino acid residue mature 8 kDa protein. At the amino acid sequence level, MDC shows less than 35% identity to other CC chemokine family members. Human MDC is expressed in dendritic cells, macrophages and activated monocytes. In addition, MDC expression is also detected in the tissues of thymus, lymph node and appendix. The gene for human MDC has been mapped to chromosome 16 rather than chromosome 17 where the genes for many human CC chemokines are clustered. Recombinant or chemically synthesized mature MDC has been shown to induce chemotaxis or Ca2+ mobilization in dendritic cells, IL2 activated NK cells, and activated T lymphocytes. A CD8+ T lymphocyte-derived secreted soluble activity that suppresses infection by primary non-syncytium-inducing and syncytium-inducing HIV1 isolates and the T cell line-adapted isolate HIV1 IIIB, has been identified as MDC. Based on aminoterminal sequence analysis, the major CD8 + T lymphocyte derived MDC protein yielded an aminoterminal sequence of YGANM, which is two amino acid residues shorter than the predicted mature MDC. The difference in potency between the two mature MDC isoforms has not been determined. |
RABBIT ANTI HUMAN MDC |
MBS221724-01mg |
MyBiosource |
0.1mg |
EUR 635 |
RABBIT ANTI HUMAN MDC |
MBS221724-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2695 |
Anti-Human MDC (CCL22) |
MBS550701-01mg |
MyBiosource |
0.1mg |
EUR 260 |
Anti-Human MDC (CCL22) |
MBS550701-02mg |
MyBiosource |
0.2mg |
EUR 335 |
Recombinant Mouse MDC/CCL22
(rMuMDC/CCL22) |
JOT-PR2006 |
Jotbody |
5µg |
EUR 205 |
|
Description: Fully biologically active when compared to standard. Determined by its ability to chemoattract human activated lymphocytes using a concentration range of 10.0-100.0 ng/ml, corresponding to a Specific Activity of >1 x 104 IU/mg. |
Recombinant Mouse MDC/CCL22
(rMuMDC/CCL22) |
PR2006 |
Bioworld Biotech |
5µg |
EUR 158 |
|
Description: Fully biologically active when compared to standard. Determined by its ability to chemoattract human activated lymphocytes using a concentration range of 10.0-100.0 ng/ml, corresponding to a Specific Activity of >1 x 104 IU/mg. |
OKAG00094-96W - MDC ELISA Kit (Mouse) |
OKAG00094-96W |
Aviva Systems Biology |
1plate:12x8-WellMicrostrips |
EUR 475 |
|
MDC Protein, Mouse, Recombinant (His Tag) |
E45M52627E1-100 |
EnoGene |
100 ug |
EUR 941.15 |
MDC Protein, Mouse, Recombinant (His Tag) |
MBS8123162-01mg |
MyBiosource |
0.1mg |
EUR 450 |
MDC Protein, Mouse, Recombinant (His Tag) |
MBS8123162-1mg |
MyBiosource |
1mg |
EUR 2530 |
MDC Protein, Mouse, Recombinant (His Tag) |
MBS8123162-5x1mg |
MyBiosource |
5x1mg |
EUR 11240 |
Rat Monoclonal anti-mouse CCL-22 (MDC) |
mAP-0175 |
Angio Proteomie |
100ug |
EUR 250 |
Macrophage Derived Chemokine, Recombinant, Mouse (MDC) |
MBS650601-002mg |
MyBiosource |
0.02mg |
EUR 665 |
Macrophage Derived Chemokine, Recombinant, Mouse (MDC) |
MBS650601-5x002mg |
MyBiosource |
5x0.02mg |
EUR 2850 |
Macrophage Derived Chemokine (MDC) Polyclonal Antibody (Mouse) |
4-PAA091Mu01 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20ul
- 100ul
- 200ul
- 1ml
- 10ml
|
|
Description: A Rabbit polyclonal antibody against Mouse Macrophage Derived Chemokine (MDC) |
Mouse Macrophage Derived Chemokine (MDC) Protein |
abx067887-100g |
Abbexa |
100 µg |
EUR 575 |
Mouse Macrophage Derived Chemokine (MDC) Protein |
20-abx067887 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
Mouse Macrophage Derived Chemokine (MDC) Protein |
abx067887-10g |
Abbexa |
10 µg |
EUR 225 |
Mouse Macrophage Derived Chemokine (MDC) Protein |
abx067887-50g |
Abbexa |
50 µg |
EUR 400 |
MDC ELISA Kit (Mouse) : 96 Wells (OKAG00094) |
OKAG00094 |
Aviva Systems Biology |
96 Wells |
EUR 715.2 |
Description: Description of target: Chemotactic for activated T-lymphocytes. May play an important role in the collaboration of dendritic cells and B-lymphocytes with T-cells in immune responses.;Species reactivity: Mouse;Application: ELISA;Assay info: Quantitative Colorimentric Sandwich ELISA;Sensitivity: 8 pg/mL |
Mouse MDC (Macrophage Derived Chemokine) ELISA Kit |
MBS8800116-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 3130 |
Mouse MDC (Macrophage Derived Chemokine) ELISA Kit |
MBS8800116-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 315 |
Mouse MDC (Macrophage Derived Chemokine) ELISA Kit |
MBS8800116-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 1710 |
Mouse MDC (Macrophage Derived Chemokine) ELISA Kit |
MBS8800116-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 385 |
Macrophage Derived Chemokine (MDC) Polyclonal Antibody (Mouse), PE |
4-PAA091Mu01-PE |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20ul
- 100ul
- 200ul
- 1ml
- 10ml
|
|
Description: A Rabbit polyclonal antibody against Mouse Macrophage Derived Chemokine (MDC). This antibody is labeled with PE. |
Macrophage Derived Chemokine (MDC) Polyclonal Antibody (Mouse), APC |
4-PAA091Mu01-APC |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20ul
- 100ul
- 200ul
- 1ml
- 10ml
|
|
Description: A Rabbit polyclonal antibody against Mouse Macrophage Derived Chemokine (MDC). This antibody is labeled with APC. |
Macrophage Derived Chemokine (MDC) Polyclonal Antibody (Mouse), Cy3 |
4-PAA091Mu01-Cy3 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20ul
- 100ul
- 200ul
- 1ml
- 10ml
|
|
Description: A Rabbit polyclonal antibody against Mouse Macrophage Derived Chemokine (MDC). This antibody is labeled with Cy3. |
Macrophage Derived Chemokine (MDC) Polyclonal Antibody (Mouse), HRP |
4-PAA091Mu01-HRP |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20ul
- 100ul
- 200ul
- 1ml
- 10ml
|
|
Description: A Rabbit polyclonal antibody against Mouse Macrophage Derived Chemokine (MDC). This antibody is labeled with HRP. |
Macrophage Derived Chemokine (MDC) Polyclonal Antibody (Mouse), FITC |
4-PAA091Mu01-FITC |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20ul
- 100ul
- 200ul
- 1ml
- 10ml
|
|
Description: A Rabbit polyclonal antibody against Mouse Macrophage Derived Chemokine (MDC). This antibody is labeled with FITC. |
Mouse Macrophage Derived Chemokine (MDC) CLIA Kit |
EKU08822-5x96T |
Biomatik Corporation |
5x96T |
EUR 4653.1 |
Mouse Macrophage Derived Chemokine (MDC) CLIA Kit |
EKN49933-5x96T |
Biomatik Corporation |
5x96T |
EUR 2895.6 |
Mouse Macrophage Derived Chemokine (MDC) CLIA Kit |
MBS2708618-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 3840 |
Mouse Macrophage Derived Chemokine (MDC) CLIA Kit |
MBS2708618-24StripWells |
MyBiosource |
24-Strip-Wells |
EUR 280 |
Mouse Macrophage Derived Chemokine (MDC) CLIA Kit |
MBS2708618-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 375 |
Mouse Macrophage Derived Chemokine (MDC) CLIA Kit |
MBS2708618-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 1985 |
Mouse Macrophage Derived Chemokine (MDC) CLIA Kit |
MBS2708618-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 490 |
Mouse Macrophage Derived Chemokine (MDC) CLIA Kit |
MBS2025230-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 6315 |
Mouse Macrophage Derived Chemokine (MDC) CLIA Kit |
MBS2025230-24StripWells |
MyBiosource |
24-Strip-Wells |
EUR 415 |
Mouse Macrophage Derived Chemokine (MDC) CLIA Kit |
MBS2025230-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 640 |
Mouse Macrophage Derived Chemokine (MDC) CLIA Kit |
MBS2025230-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3480 |
Mouse Macrophage Derived Chemokine (MDC) CLIA Kit |
MBS2025230-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 865 |
Mouse Macrophage Derived Chemokine (MDC)CLIA Kit |
SCA091Mu-10x96wellstestplate |
Cloud-Clone |
10x96-wells test plate |
EUR 6965.86 |
|
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Mouse Macrophage Derived Chemokine (MDC) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Mouse Macrophage Derived Chemokine (MDC)CLIA Kit |
SCA091Mu-1x48wellstestplate |
Cloud-Clone |
1x48-wells test plate |
EUR 678.84 |
|
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Mouse Macrophage Derived Chemokine (MDC) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Mouse Macrophage Derived Chemokine (MDC)CLIA Kit |
SCA091Mu-1x96wellstestplate |
Cloud-Clone |
1x96-wells test plate |
EUR 918.34 |
|
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Mouse Macrophage Derived Chemokine (MDC) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Mouse Macrophage Derived Chemokine (MDC)CLIA Kit |
SCA091Mu-5x96wellstestplate |
Cloud-Clone |
5x96-wells test plate |
EUR 3772.51 |
|
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Mouse Macrophage Derived Chemokine (MDC) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Mouse Macrophage Derived Chemokine (MDC) CLIA Kit |
4-SCA091Mu |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
|
- 1 plate of 96 wells
- 5 plates of 96 wells
- 10 plates of 96 wells
|
|
Description: Double-antibody Sandwich chemiluminescent immunoassay for detection of Mouse Macrophage Derived Chemokine (MDC)Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids |
Mouse Macrophage Derived Chemokine (MDC) ELISA Kit |
DLR-MDC-Mu |
DL Develop |
96T |
EUR 317 |
|
Description: serum, plasma or other biological fluids. |
Mouse Macrophage Derived Chemokine (MDC) ELISA Kit |
DLR-MDC-Mu-48T |
DL Develop |
48T |
EUR 462 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Macrophage Derived Chemokine (MDC) in samples from serum, plasma or other biological fluids. |
Mouse Macrophage Derived Chemokine (MDC) ELISA Kit |
DLR-MDC-Mu-96T |
DL Develop |
96T |
EUR 590.4 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Macrophage Derived Chemokine (MDC) in samples from serum, plasma or other biological fluids. |
Mouse Macrophage Derived Chemokine (MDC) ELISA Kit |
DL-MDC-Mu |
DL Develop |
96T |
EUR 302 |
|
Description: serum, plasma or other biological fluids. |
Mouse Macrophage Derived Chemokine (MDC) ELISA Kit |
EKU05741-5x96T |
Biomatik Corporation |
5x96T |
EUR 2682.8 |
Mouse Macrophage Derived Chemokine (MDC) ELISA Kit |
EKU11217-5x96T |
Biomatik Corporation |
5x96T |
EUR 3221.45 |
Mouse Macrophage Derived Chemokine (MDC) ELISA Kit |
EK15392 |
SAB |
96Т |
EUR 768 |
|
Mouse Macrophage Derived Chemokine (MDC) ELISA Kit |
EKN46852-5x96T |
Biomatik Corporation |
5x96T |
EUR 1830.18 |
Mouse Macrophage Derived Chemokine (MDC) ELISA Kit |
EKN52328-5x96T |
Biomatik Corporation |
5x96T |
EUR 2004.03 |
Mouse Macrophage Derived Chemokine (MDC) ELISA kit |
EIA06028m |
Enlibio |
each |
EUR 480 |
Mouse Macrophage Derived Chemokine (MDC) ELISA Kit |
MBS4500965-10x96Tests |
MyBiosource |
10x96Tests |
EUR 3885 |
Mouse Macrophage Derived Chemokine (MDC) ELISA Kit |
MBS4500965-48Tests |
MyBiosource |
48Tests |
EUR 350 |
Mouse Macrophage Derived Chemokine (MDC) ELISA Kit |
MBS4500965-5x96Tests |
MyBiosource |
5x96Tests |
EUR 1990 |
Mouse Macrophage Derived Chemokine (MDC) ELISA Kit |
MBS4500965-96Test |
MyBiosource |
96Test |
EUR 450 |
Mouse Macrophage Derived Chemokine (MDC) ELISA Kit |
MBS454691-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 3740 |
Mouse Macrophage Derived Chemokine (MDC) ELISA Kit |
MBS454691-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 345 |
Mouse Macrophage Derived Chemokine (MDC) ELISA Kit |
MBS454691-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 1915 |
Mouse Macrophage Derived Chemokine (MDC) ELISA Kit |
MBS454691-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 435 |
Mouse Macrophage Derived Chemokine (MDC) ELISA kit |
MBS264933-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 3290 |
Mouse Macrophage Derived Chemokine (MDC) ELISA kit |
MBS264933-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 295 |
Mouse Macrophage Derived Chemokine (MDC) ELISA kit |
MBS264933-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 1800 |
Mouse Macrophage Derived Chemokine (MDC) ELISA kit |
MBS264933-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 450 |
Mouse Macrophage Derived Chemokine (MDC) ELISA Kit |
MBS2022508-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 4070 |
Mouse Macrophage Derived Chemokine (MDC) ELISA Kit |
MBS2022508-24StripWells |
MyBiosource |
24-Strip-Wells |
EUR 295 |
Mouse Macrophage Derived Chemokine (MDC) ELISA Kit |
MBS2022508-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 420 |
Mouse Macrophage Derived Chemokine (MDC) ELISA Kit |
MBS2022508-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 2225 |
Mouse Macrophage Derived Chemokine (MDC) ELISA Kit |
MBS2022508-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 550 |
Mouse Macrophage Derived Chemokine (MDC) ELISA Kit |
MBS2701143-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 2275 |
Mouse Macrophage Derived Chemokine (MDC) ELISA Kit |
MBS2701143-24StripWells |
MyBiosource |
24-Strip-Wells |
EUR 225 |
Mouse Macrophage Derived Chemokine (MDC) ELISA Kit |
MBS2701143-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 280 |
Conclusion: SSc sufferers who produce autoantibodies to elements of the Th/To advanced have a scientific phenotype characterised by restricted cutaneous illness and pulmonary involvement. Our findings present that the presence of any Th/To autoantibody might have a protecting impact in opposition to contemporaneous most cancers.